• Exchange: Continuous
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF/P:SM

30.090 EUR 0.035 0.12%

As of 11:38:00 ET on 08/29/2014.

Snapshot for Grifols SA (GRF/P)

Open: 30.050 Day's Range: 29.965 - 30.265 Volume: 52,414
Previous Close: 30.125 52wk Range: 20.894 - 34.600 1-Yr Rtn: +29.78%

Stock Chart for GRF/P

No chart data available.
  • GRF/P:SM 30.065
  • 1D
  • 1M
  • 1Y
30.125
Interactive GRF/P Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF/P

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.0385
Relative P/E vs. IBEX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 1.7660
Est. PEG Ratio 1.2476
Market Cap (M EUR) 11,482.03
Shares Outstanding (M) 130.71
30 Day Average Volume 366,124
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.67%
Cash Dividend (EUR) 0.1585
Dividend Ex-Date 06/05/2014
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF/P

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF/P

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEORamon Riera RocaExec VP/Pres:Global Commercial
Alfredo Arroyo GuerraVP/CFOCarlos Roura FernandezVP/Pres:Global Industrial
More Company Profile & Key Executives for GRF/P

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil